Healthcare -
Biotechnology - NASDAQ - US
$ 1.185
-1.25 %
$ 76.1 M
Market Cap
-0.76
P/E
INZY - STOCK-BASED COMPENSATION
Stock-based Compensation INZY - Inozyme Pharma, Inc.
7.04 M
LAST VALUE
-0.89%
2 YEAR CAGR
73.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR